Ventrus Biosciences to Present at the Leerink Swann Global Healthcare Conference

[at noodls] – NEW YORK, Feb. 11, 2013 (GLOBE NEWSWIRE) — Ventrus Biosciences, Inc. (Nasdaq:VTUS), a pharmaceutical company focused on developing and commercializing gastrointestinal products, today announced that Dr. … more

View todays social media effects on VTUS

View the latest stocks trending across Twitter. Click to view dashboard

See who Ventrus is hiring next, click here to view